Article metrics

Download PDFPDF

443 Open-label, phase 2 study to assess the safety of mogamulizumab at 2 mg/kg Q4W maintenance dosing in patients with relapsed/refractory MF/SS subtypes of CTCL
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to January 2024

AbstractFullPdf
Nov 2021182010
Dec 20216401
Jan 202244010
Feb 20223001
Mar 202215602
Apr 20223406
May 202228012
Jun 20221605
Jul 2022804
Aug 20221602
Sep 20221006
Oct 202222011
Nov 20221203
Dec 20221004
Jan 2023406
Feb 2023602
Mar 2023402
Apr 20231002
May 2023805
Jun 2023604
Jul 2023408
Aug 2023404
Sep 20231000
Oct 2023604
Nov 20233208
Dec 20234002
Jan 20241801
Total7840125